Journal of Clinical Oncology · 2010 · 313 citations · 22 references
MedicineMolecular BiologyMolecular GeneticsMolecular OncologyNeuro-oncologyPediatric OncologyBrain TumorsMolecular Tumor ProfilingPediatric Brain TumorsPediatric Cancer BiologyPediatric Neuro-oncologyPediatric TumorsMicroarray AnalysisPediatric Brain Tumor BiologyPediatric High-grade GliomaPediatric Neuro-oncology TrialsPlatelet-derived Growth Factor ReceptorsSingle-nucleotide Polymorphism AnalysisSnp ArraysWhole-genome Copy Number Profiling
Diffuse intrinsic pontine glioma is a devastating pediatric cancer with no effective therapy, and clinical trials have failed partly because researchers have assumed its biology mirrors that of adult high‑grade gliomas. This study aims to deepen the understanding of DIPG biology to enable the development of therapies specifically tailored to children’s disease. The authors performed the first high‑resolution SNP‑based DNA microarray analysis of 11 DIPG samples, validating array findings with PCR, FISH, immunohistochemistry, and microsatellite analysis under institutional ethics approval. They found recurrent PDGFRA gains in 36 % of tumors with corresponding expression, low‑level PARP‑1 gains in three cases, and enrichment of DNA‑repair pathway loss‑of‑heterozygosity, highlighting PDGFRA and PARP‑1 as promising therapeutic targets.
Diffuse intrinsic pontine glioma (DIPG) is one of the most devastating of pediatric malignancies and one for which no effective therapy exists. A major contributor to the failure of therapeutic trials is the assumption that biologic properties of brainstem tumors in children are identical to cerebral high-grade gliomas of adults. A better understanding of the biology of DIPG itself is needed in order to develop agents targeted more specifically to these children's disease. Herein, we address this lack of knowledge by performing the first high-resolution single nucleotide polymorphism (SNP) -based DNA microarray analysis of a series of DIPGs.Eleven samples (nine postmortem and two pretreatment surgical samples), the largest series thus far examined, were hybridized to SNP arrays (250 k or 6.0). The study was approved by the research ethics board at our institution. All array findings were validated using quantitative polymerase chain reaction, fluorescence in situ hybridization, immunohistochemistry, and/or microsatellite analysis.Analysis of DIPG copy number alterations showed recurrent changes distinct from those of pediatric supratentorial high-grade astrocytomas. Thirty-six percent of DIPGs had gains in platelet-derived growth factor receptor alpha (PDGFRA; 4 to 18 copies) and all showed PDGFR-alpha expression. Low-level gains in poly (ADP-ribose) polymerase (PARP) -1 were identified in three cases. Pathway analysis revealed genes with loss of heterozygosity were enriched for DNA repair pathways.To our knowledge, our data provides the first, comprehensive high-resolution genomic analysis of pediatric DIPG. Our findings of recurrent involvement of the PDGFR pathway as well as defects in DNA repair pathways coupled with gain of PARP-1 highlight two potential, biologically based, therapeutic targets directed specifically at this devastating disease.
22
Valérie Schreiber, Jean‐Christophe Amé, Pascal Dollé et al. · Journal of Biological Chemistry · 2002 · 705 citations · Full text
A genotype calling algorithm for affymetrix SNP arrays
Nusrat Rabbee, Terence P. Speed · Bioinformatics · 2005 · 362 citations · Full text
Fiona Dungey, Dana A. Löser, Anthony J. Chalmers · International Journal of Radiation Oncology*Biology*Physics · 2008 · 218 citations · Full text